Home
Contact
Home
Contact
Home
Endeavor
Uncategorized
Ipca Labs’ board approves acquisition of over 26% stake in Lyka Labs
Ipca Labs’ board approves acquisition of over 26% stake in Lyka Labs
Lyka Labs is engaged in the manufacturing and marketing of injectables, lyophilized injectables and topical formulations
Powered by
WPeMatico
Scroll to top